Brief: Zim Laboratories March-Quarter Consol Profit Flat
02/06/2020 14:18
June 2 (Reuters) - Zim Laboratories Ltd ZIML.BO :
* MARCH-QUARTER CONSOL PAT 23 MILLION RUPEES VERSUS 23
MILLION
RUPEES
* MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 692 MILLION
RUPEES
VERSUS 945.9 MILLION RUPEES
Further company coverage: ZIML.BO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zim Laboratories
See all newsBrief: Zim Laboratories Gets Marketing Authorization For Dabigatran Etexilate Capsules In Italy, Europe
Brief: Zim Laboratories March-Quarter Consol Net Profit 37.4 Mln Rupees
Brief: Zim Laboratories To Consider Fund Raising Via Securities Issuance
Brief: Zim Laboratories Gets Marketing Authorization For Tamsulosin + Dutasteride Capsules In Australia
India's Zim Laboratories up after getting marketing authorization for migraine drug in Australia